intracellular gsh levels were enhanced using l-2-oxothiazolidine-4-carboxylate ( otc ) , which delivers cysteine intracellularly , and suppressed by buthionine sulfoximine ( bso ) , which inhibits gamma-glutamylcysteine synthetase .
C0054252
bso
C0017037
gamma-glutamylcysteine synthetase